Reduction of isoflurane minimal alveolar concentration by remifentanil

Anesthesiology

Volumn 85, Issue 4, 1996, Pages 721-728

  Lang, E ^a   Kapila, A ^b   Shlugman, D ^b   Hoke, J F ^c   Sebel, P S ^a   Glass, P S A ^b,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Glaxo Wellcome

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesics, opioid: remifentanil; Anesthetic techniques: computer controlled infusion; Anesthetics, intravenous: remifentanil; Anesthetics, volatile: isoflurane; Interactions (drug): isoflurane remifentanil; Pharmacodynamics: remifentanil; isoflurane

Indexed keywords

ALFENTANIL; FENTANYL; INHALATION ANESTHETIC AGENT; ISOFLURANE; OPIATE AGONIST; REMIFENTANIL; SUFENTANIL;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CLINICAL TRIAL; COMPUTER ASSISTED DRUG THERAPY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG POTENCY; FEMALE; HUMAN; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MULTICENTER STUDY; MUSCLE RIGIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANESTHETICS, INHALATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HUMANS; INFUSION PUMPS; ISOFLURANE; MALE; MIDDLE AGED; MOVEMENT; PIPERIDINES; PULMONARY ALVEOLI;

EID: 0029858302     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199610000-00006     Document Type: Article

References (31)

1. Eger EI, Saidman LJ, Brandstater B: Minimum alveolar anestqhetic concentration: A standard of anesthetic potency. ANESTHESIOLOGY 1965; 26:756-63
2. McEwan AI, Smith C, Dyar O, Goodman D, Glass PSA: Isoflurane MAC reduction by fentanyl. ANESTHESIOLOGY 1993; 78:864-9
3. Sebel PS, Glass PSA, Fletcher JE, Murphy MR, Gallagher C, Quill T: Reduction of the MAC of desflurane with fentanyl. ANESTHESIOLOGY 1992; 76:52-9
4. Westmoreland CL, Sebel PS, Gropper A: Fentanyl or alfentanil decreases the minimum alveolar anesthetic concentration of isoflurane in surgical patients. Anesth Analg 1994; 78:23-8
5. Brunner MD, Braithwaite P, Jhaveri R, McEwan AI, Goodman DK, Smith LR, Glass PSA: The MAC reduction of isoflurane by sufentanil. Br J Anaesth 1994; 72:42-6
6. Feldman PL, James MK, Brackee MF, Bilotta JM, Schuster SV, Lahey AP, Lutz MW, Johnson MR, Leighton HJ: Design, synthesis and pharmacological evaluation of ultrashort to long-acting opioid analgesics. J Med Chem 1991; 34:2202-8
7. Egan TD, Minto C, Lemmens HJM, Muir KT, Hermann DJ, Shafer SL: Remifentanil versus alfentanil: comparative pharmacodynamics (abstract). ANESTHESIOLOGY 1994; 81:A374
8. Glass PSA, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH, Grosse CM, Hermann D: Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B). Anesth Analg 1993; 77:1031-40
9. Egan TD, Lemmens HJM, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL: The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. ANESTHESIOLOGY 1993; 79:881-92
10. Westmoreland CL, Hoke JF, Sebel PS, Hug CC, Muir KT: Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. ANESTHESIOLOGY 1993; 79:893-903
11. Saidman LJ, Eger EI: Effect of nitrous oxide and of narcotic premedication on the alveolar concentration of halothane required for anesthesia. ANESTHESIOLOGY 1964; 26:302-6
12. Munson ES, Saidman LJ, Eger EI: Effect of nitrous oxide and morphine on the minimum anesthetic concentration of fluroxene. ANESTHESIOLOGY 1965; 26:134-9
13. Scott JC, Ponganis KV, Stanski DR: EEG quantitation of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil. ANESTHESIOLOGY 1985; 62:234-41
14. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J: Simultaneous modelling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin Pharm Ther 1979; 25:358-71
15. Glass PSA, Jacobs JR, Smith RL, Ginsberg B, Quill TJ, Bai SA, Reves JG: Pharmacokinetic model-driven infusion of fentanyl: Assessment of accuracy. ANESTHESIOLOGY 1990; 73:1082-90
16. Dixon WJ: The up down method for small samples. J Am Stat Soc 1965; 60:967-78
17. Stevens WC, Dolan WM, Gibbons RT, White A, Eger EI, Miller RD, Dejong RH, Elashoff RM: Minimum alveolar concentration (MAC) of isoflurane with and without nitrous oxide in patients of various ages. ANESTHESIOLOGY 1975; 42:197-200
18. Grosse CM, Davis IM, Arrendal RF, Jersey J, Amin J: Determination of remifentanil in human blood by liquid-liquid extraction and capillary GC-HRMS-SIM using deuterated internal standard. J Pharm Biomed Anal 1994; 12:195-203
19. Murphy MR, Hug CC: The anesthetic potency of fentanyl in terms of its reduction of enflurane MAC. ANESTHESIOLOGY 1982; 57:485-8
20. Stanski DR, Shafer SL: Quantifying Anesthetic drug interaction: Implications for drug dosing. ANESTHESIOLOGY 1995; 83:1-5
21. Hughes MA, Glass PSA, Jacobs JR: Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. ANESTHESIOLOGY 1992; 76:334-41
22. Ghouri AF, M. H, White PF: Recovery profile after desflurane-nitrous oxide versus isoflurane nitrous oxide in outpatients. ANESTHESIOLOGY 1991; 74:419-24
23. de Lange S, Boscoe MJ, Stanley TH, Pace N: Comparison of sufentanil O2 and fentanyl-O2 for coronary artery surgery. ANESTHESIOLOGY 1982; 56:112-8
24. Van de Walle J, Lauwers P, Ariaensen H: Double blind comparison of fentanyl and sufentanil in anaesthesia. Acta Anaesthcsiol Belg 1976; 27:129-38
25. Scott JC, Cooke JE, Stanski OR: Electroencephalographic quantitation of opioid effect: Comparative pharmacodynamics of fentanyl and sufentanil. ANESTHESIOLOGY 1991; 74:34
26. Glass PSA, Kapila A, Muir KT, Hermann DJ, Shiraishi M: A model to determine the relative potency of mu opioids: Alfentanil versus remifentanil (abstract). ANESTHESIOLOGY 1993; 79:A378
27. Gourlay GK, Kowalski SR, Plummer JL, Cousins MJ, Armstrong PJ: Fenianyl blood concentration analgesic response relationship in the treatment of postoperative pain. Anesth Analg 1988; 67:329-37
28. Glass PSA, Doherty M, Jacobs JR, Goodman D, Smith LR: Plasma concentration of fentanyl, with 70% nitrous oxide, to prevent movement at skin incision. ANESTHESIOLOGY 1993; 78:842-7
29. Ausems ME, Hug CC, Jr., Stanski DR, Burm AGL: Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. ANESTHESIOLOGY 1986; 65:362-73
30. Lehmann KA, Gerhard A, Horrichs-Haermeyer G, Grond S, Zech D: Postoperative patient-controlled analgesia with sufentanil: Analgesic efficacy and minimum effective concentrations. Acta Anaesthesiol Scand 1991; 35:221-5
31. Cunningham FE, Hoffman WE, Bughman VL: Comparative pharmacodynamics of remifentanil, a new short acting opioid, GI90291A the active metabolite and alfentanil (abstract). ANESTHESIOLOGY 1993; 79:A712